4.7 Article

Runx1 promotes scar deposition and inhibits myocardial proliferation and survival during zebrafish heart regeneration

Journal

DEVELOPMENT
Volume 147, Issue 8, Pages -

Publisher

COMPANY BIOLOGISTS LTD
DOI: 10.1242/dev.186569

Keywords

Heart; Regeneration; Runx1; ScRNA-seq; Zebrafish

Funding

  1. British Heart Foundation [FS/14/73/31107, PG/15/111/31939, PG/14/39/30865, CH/11/1/28798, RG/08/003/25264]
  2. European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [715895]
  3. European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (ERC-2016-STG)
  4. Medical Research Council-Molecular Haematology Unit grant [4050189188]
  5. British Heart Foundation Centre of Regenerative Medicine [RM/13/3/30159]
  6. British Heart Foundation Centre of Research Excellence Oxford [RE/13/1/30181]
  7. University of Oxford
  8. European Research Council (ERC) [715895] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

Runx1 is a transcription factor that plays a key role in determining the proliferative and differential state of multiple cell types, during both development and adulthood. Here, we report how Runx1 is specifically upregulated at the injury site during zebrafish heart regeneration, and that absence of runx1 results in increased myocardial survival and proliferation, and overall heart regeneration, accompanied by decreased fibrosis. Using single cell sequencing, we found that the wild-type injury site consists of Runx1-positive endocardial cells and thrombocytes that induce expression of smooth muscle and collagen genes. Both these populations cannot be identified in runx1 mutant wounds that contain less collagen and fibrin. The reduction in fibrin in the mutant is further explained by reduced myofibroblast formation and upregulation of components of the fibrin degradation pathway, including plasminogen receptor annexin 2A as well as downregulation of plasminogen activator inhibitor serpinel in myocardium and endocardium, resulting in increased levels of plasminogen. Our findings suggest that Runx1 controls the regenerative response of multiple cardiac cell types and that targeting Runx1 is a novel therapeutic strategy for inducing endogenous heart repair.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available